Literature DB >> 31767551

Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Roman Maslennikov1, Chavdar Pavlov1, Vladimir Ivashkin1.   

Abstract

BACKGROUND/AIMS: Small intestinal bacterial overgrowth (SIBO) and hemodynamic changes are common in cirrhosis. We wanted to examine our hypothesis whether SIBO leads to hemodynamic changes in cirrhosis.
MATERIALS AND METHODS: A total of 50 patients with cirrhosis and 15 healthy controls were enrolled in a pilot prospective study. All participants underwent the lactulose hydrogen breath test for SIBO and echocardiography with a simultaneous assessment of blood pressure and heart rate. Cardiac output and systemic vascular resistance were calculated.
RESULTS: Study participants with SIBO had a lower systolic blood pressure and systemic vascular resistance compared to those without SIBO and to healthy controls (110.2±12.3 mmHg vs. 126.2±21.0 mmHg and 121.2±9.8 mmHg; p=0.005 and p=0.011, respectively; 1312±352 dyn•s•cm-5 vs. 1704±424 dyn•s•cm-5 and 1648±272 dyn•s•cm-5; p=0.001 and p=0.006, respectively), but a higher cardiac output (5.38±1.41 l/min vs. 4.52±1.03 l/min and 4.40±0.68 l/min; p=0.034 and p=0.041, respectively) and C-reactive protein (10.5[1.2-16.5] mg/l vs. 2.8[0.6-9.1] mg/l; p=0.028; no comparison with healthy controls). There were no significant differences between patients without SIBO and healthy controls with regard to systolic blood pressure (p=0.554), systemic vascular resistance (p=0.874), and cardiac output (p=0.795). SIBO was associated with vasodilation and hyperdynamic circulation in decompensated cirrhosis (p=0.002; p=0.012), but not in compensated cirrhosis (p=1.000; p=0.474).
CONCLUSIONS: SIBO is associated with hyperdynamic circulation and other hemodynamic changes in cirrhosis and may be a principal factor causing these through systemic inflammation.

Entities:  

Mesh:

Year:  2019        PMID: 31767551      PMCID: PMC6883995          DOI: 10.5152/tjg.2019.18551

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  29 in total

1.  The cardiac output at rest in Laennec's cirrhosis.

Authors:  H J KOWALSKI; W H ABELMANN
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

2.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 3.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

Review 4.  Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE).

Authors:  Thomas H Marwick; Thierry C Gillebert; Gerard Aurigemma; Julio Chirinos; Genevieve Derumeaux; Maurizio Galderisi; John Gottdiener; Brian Haluska; Elizabeth Ofili; Patrick Segers; Roxy Senior; Robyn J Tapp; Jose L Zamorano
Journal:  J Am Soc Echocardiogr       Date:  2015-07       Impact factor: 5.251

Review 5.  How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.

Authors:  Ali Rezaie; Mark Pimentel; Satish S Rao
Journal:  Curr Gastroenterol Rep       Date:  2016-02

Review 6.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

Authors:  Mauro Bernardi; Richard Moreau; Paolo Angeli; Bernd Schnabl; Vicente Arroyo
Journal:  J Hepatol       Date:  2015-07-17       Impact factor: 25.083

Review 7.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

Review 8.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 9.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Cirrhotic cardiomyopathy: review of pathophysiology and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  Hepatol Int       Date:  2014-07       Impact factor: 6.047

View more
  6 in total

1.  Cecal Metabolomic Fingerprint of Unscathed Rats: Does It Reflect the Good Response to a Provocative Decompression?

Authors:  Anne-Virginie Desruelle; Sébastien de Maistre; Sandrine Gaillard; Simone Richard; Catherine Tardivel; Jean-Charles Martin; Jean-Eric Blatteau; Alain Boussuges; Sarah Rives; Jean-Jacques Risso; Nicolas Vallee
Journal:  Front Physiol       Date:  2022-05-17       Impact factor: 4.755

2.  Gut dysbiosis and body composition in cirrhosis.

Authors:  Roman Maslennikov; Vladimir Ivashkin; Aliya Alieva; Elena Poluektova; Anna Kudryavtseva; George Krasnov; Maria Zharkova; Yuri Zharikov
Journal:  World J Hepatol       Date:  2022-06-27

3.  Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.

Authors:  Roman Maslennikov; Vladimir Ivashkin; Irina Efremova; Elena Poluektova; Anna Kudryavtseva; George Krasnov
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742

4.  Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial.

Authors:  Roman Maslennikov; Irina Efremova; Vladimir Ivashkin; Maria Zharkova; Elena Poluektova; Elena Shirokova; Konstantin Ivashkin
Journal:  World J Hepatol       Date:  2022-08-27

5.  Cecal metabolome fingerprint in a rat model of decompression sickness with neurological disorders.

Authors:  Sébastien de Maistre; Sandrine Gaillard; Jean-Charles Martin; Simone Richard; Alain Boussuges; Sarah Rives; Anne-Virginie Desruelle; Jean-Eric Blatteau; Catherine Tardivel; Jean-Jacques Risso; Nicolas Vallée
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

6.  Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis.

Authors:  Roman Maslennikov; Vladimir Ivashkin; Irina Efremova; Aliya Alieva; Ekaterina Kashuh; Ekaterina Tsvetaeva; Elena Poluektova; Elena Shirokova; Konstantin Ivashkin
Journal:  World J Hepatol       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.